-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
OnabotulinumtoxinA for the treatment of overactive bladder
Altaf Mangera & Christopher R Chapple
Review: Clinical Trail Outcomes: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
Concept, characteristics and implications of cluster randomization
Monica Taljaard, Jeremy M Grimshaw
Editorial: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
HIV pre-exposure prophylaxis trials: the road to success
Melanie R Nicol, Jessica L Adams, Angela DM Kashuba
Review: Clinical Trail Outcomes: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Considerations in the design of clinical trials for relapsing multiple sclerosis
Richard Nicholas, Tim Friede
Clinical Trail Methodology: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation
-
Tribulations of trials for antibacterial drugs: interview with Mark Leuchtenberger and Scott Hopkins
Leuchtenberger, Scott Hopkins
Interview: Clinical Investigation